M. Delcroix (Leuven, Belgium), G. Simonneau (Clamart, France)
"Anti-pulmonary hypertensive" protection in erythropoietin-overexpressing mice in normoxia and hypoxia
N. Weissmann, D. Manz, D. Buchspies, S. Keller, T. Mehling, R. Voswinckel, K. Quanz, H. A. Ghofrani, R. T. Schermuly, L. Fink, W. Seeger, M. Gassmann, F. Grimminger (Giessen, Germany; Zurich, Switzerland)
|  |
Vasoactive intestinal peptide (VIP) markedly attenuates pulmonary hypertension in fawn-hooded rats
S. A. Hamidi, K. G. Dickman, S. Mathew, S. I. Said (Northport, Stony Brook, United States Of America)
|  |
Cigarette smoke exposure induces endothelial dysfunction in pulmonary arteries in the guinea pig
A. Martinez, V. I. Peinado, B. Reyes, E. Ardite, R. Rodriguez-Roisin, J. Roca, J. A. Barberà (Barcelona, Spain)
| |
Platelet-activating factor-acetylhydrolase (PAF-AH) activity in pulmonary arterial hypertension (PAH)
R. Quarck, E. Ninio, H. Durand, W. Daenen, D. Marion (Leuven, Belgium; Paris, France)
| |
Endothelin-1 and endothelin-3 plasma levels in severe idiopathic pulmonary arterial hypertension
D. Montani, O. Sitbon, W. Fischli, M. Clozel, G. Simonneau, M. Humbert (Clamart, France; Allschwil, Switzerland)
| |
Gene polymorphisms of endothelial nitric oxide synthase in pulmonary arterial hypertension
P. Jansa, M. Jachymova, M. Skvarilova, H. Sladkova, T. Palecek, M. Aschermann (Prague, Czech Republic)
| |
Contribution of angiopoietin/Tie2 pathway to pulmonary artery smooth muscle hyperplasia in idiopathic pulmonary hypertension
L. Dewachter, E. Fadel, M. Humbert, A. M. Barlier-Mur, S. Adnot, R. Naeije, S. Eddahibi (Creteil, Plessis Robinson, Clamart, France; Brussels, Belgium)
| |
Potential association between pulmonary hypertension in COPD and monocyte chemoattractant protein (MCP)-1
A. Chaouat, B. Sztrymf, L. I. Tu, C. Chouaid, B. Housset, E. Weitzenblum, S. Adnot (Strasbourg, Créteil, Paris, France)
| |